Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
about
Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis. Alpha-1 protocolBiomarkers of patient intrinsic risk for upper and lower airway injury after exposure to the World Trade Center atrocityLymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugsLow serum levels of alpha1 anti-trypsin (α1-AT) and risk of airflow obstruction in non-primary α1-AT-deficient patients with compensated chronic liver diseaseThe significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygoteDistinguishing adult-onset asthma from COPD: a review and a new approach.Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes.Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency allelesA Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging PhenotypesA study of common Mendelian disease carriers across ageing British cohorts: meta-analyses reveal heterozygosity for alpha 1-antitrypsin deficiency increases respiratory capacity and heightExome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12.The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult.Update in Chronic Obstructive Pulmonary Disease 2014.Chronic Obstructive Pulmonary Disease Genetics: A Review of the Past and a Look Into the FutureRisk of Lung Disease in PI MZ Heterozygotes. Current Status and Future Research Directions.Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.Alpha-1 Antitrypsin Investigations Using Animal Models of EmphysemaPiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.Prevalence, Risk Factors and Diagnostic Accuracy of COPD Among Smokers in Primary Care.Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD.Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicine.The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.α1-Antitrypsin deficiency.Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.A functional SNP upstream of the ADRB2 gene is associated with COPD.Reply: interactions and clarifying group-specific estimates by using stratification.The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.Alpha-1 antitrypsin deficiency: outstanding questions and future directions.Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial GroupsSequencing Alpha-1 MZ Individuals Shows Frequent Biallelic MutationsGenome-wide association study of lung function and clinical implication in heavy smokers
P2860
Q23911017-54B23022-F8F9-410F-A304-93CF7BE934FCQ27908435-FF13C92A-F25E-4D62-8628-D8605F8C8ABBQ28069399-C7BDFC0E-6BDF-4B23-9B1F-5D7A8557F7DBQ28393624-F28CC6C1-5630-4D34-8115-12A4F892917AQ34039609-33F95835-6CD7-4ABB-B458-735CAB5E63A2Q34198033-B17C0401-9E5B-4A5F-A6EB-FAE923757C69Q35063726-73FD6CC0-C431-49A7-967C-31B3CDD18BC2Q35937953-F1D61688-DF1E-43A7-A8FC-ABD58644C057Q36128611-95BF179D-D16B-40D3-AE01-CFE0F4732108Q36761965-D3491862-6866-404E-BB6A-70ABA31BCBB5Q36968835-31E32DD4-F417-42C3-9110-0C9B363459EAQ38322575-334FB8E2-E33C-4D39-B423-06C8E0A43116Q38604630-679E5992-6D61-4379-B84D-6738A63C6A3BQ38620368-E8F1038F-E293-4507-BE12-510136C17770Q38636068-6C34DB74-9947-48C0-929E-101E672F027BQ38827548-B0CFBCF9-5955-4716-9119-1D4134111C31Q38988633-F8518708-71A7-443B-803E-EBAE3AD2F861Q40980448-60471FAE-E3F5-4BFE-BA32-FCAE34CF0A2EQ41429852-B9DF5A3C-C672-4DCC-8989-AD0B2151B0E3Q41614676-FC8E6EF2-B49B-4232-A85E-D513A5BB1B37Q41728444-CBDA7C5B-46AE-49BD-9210-33FBA6F21976Q43404339-9C5D79BF-0E61-4409-BC3B-21CA9261D501Q49961017-6447E02B-1F60-44AC-B405-71B4F71347B3Q51465407-F9BC1AB1-E3C6-4531-A490-D0DF4AF028A3Q51481224-B0A05BC2-4E21-48B8-8DD1-561B0B06F6D9Q51568269-12B988DF-0608-4C89-9872-9BC40CEAE155Q52626684-A91554E7-835C-4746-8E59-FC47904BDEE9Q54986385-88FEFEDE-E35D-4566-B680-F4393E230FA9Q55011363-E61E787F-C075-4CC6-846B-3E8CE6216CEBQ55666746-E8E9E9C6-3878-4DAF-B768-8D662723561AQ57909754-74222D9C-BB6C-47C2-8A7F-2101EBA85057Q58762724-52F6BED6-52F9-4736-8769-FCE03E938A7DQ58805933-33B6D347-C443-43A6-BD28-3D19367ED8C2
P2860
Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Clarification of the risk of c ...... deficiency PiMZ heterozygotes.
@en
Clarification of the risk of c ...... deficiency PiMZ heterozygotes.
@nl
type
label
Clarification of the risk of c ...... deficiency PiMZ heterozygotes.
@en
Clarification of the risk of c ...... deficiency PiMZ heterozygotes.
@nl
prefLabel
Clarification of the risk of c ...... deficiency PiMZ heterozygotes.
@en
Clarification of the risk of c ...... deficiency PiMZ heterozygotes.
@nl
P2093
P2860
P50
P1476
Clarification of the risk of c ...... deficiency PiMZ heterozygotes.
@en
P2093
Catherine A O'Connor
Craig P Hersh
Edwin K Silverman
Kevin Molloy
Noel G McElvaney
Shane J O'Neill
Valerie B Morris
P2860
P304
P356
10.1164/RCCM.201311-1984OC
P407
P577
2014-02-01T00:00:00Z